Paroxetine Tablet, Film Coated
Product Images NDC 68071-3843

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68071-3843). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3843 1)

Paroxetine 10 mg tablets packaging label from NuCare Pharmaceuticals, Inc. The label indicates #30 film-coated tablets with each tablet containing 10 mg of paroxetine hydrochloride USP. The label includes manufacturer information, usage instructions, barcode, lot number, expiration date, and a warning to keep out of reach of children. Temperature storage conditions of 68-77°F are specified.*

FDA Label Image

Picture1 (Image 05)

Chemical structure diagram of paroxetine hydrochloride hemihydrate, showing its molecular arrangement including fluorophenyl, piperidine, and dioxolane rings.*

FDA Label Image

Figure (Image 06)

A pharmacokinetic (PK) chart showing fold change and 90% confidence intervals in Cmax and AUC for various interacting drugs relative to a reference. Drugs listed include Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg, with fold changes plotted on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Figure2 (Image 07)

A chart depicting fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC relative to reference, comparing several interacting drugs including Cimetidine 300 mg three times daily, Phenobarbital 100 mg once daily, Phenytoin 300 mg once daily, Digoxin 0.25 mg once daily, and Diazepam 5 mg three times daily.*

FDA Label Image

Figure 3 (Image 08)

A pharmacokinetic fold change chart with 90% confidence intervals showing the effects of renal impairment (mild, moderate, severe), hepatic impairment, age over 65 at different doses (20 mg, 30 mg, 40 mg once daily), and gender (males) on Cmax, Cmin, and AUC parameters relative to reference values.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.